Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.
paper
Primary
Public
- Authors
- Schwantes-An, Tae-Hwi; Zhang, Juan; Chen, Li-Shiun; Hartz, Sarah M; Culverhouse, Robert C; Chen, Xiangning; Coon, Hilary; Frank, Josef; Kamens, Helen M; Konte, Bettina; Kovanen, Leena; Latvala, Antti; Legrand, Lisa N; Maher, Brion S; Melroy, Whitney E; Nelson, Elliot C; Reid, Mark W; Robinson, Jason D; Shen, Pei-Hong; Yang, Bao-Zhu; Andrews, Judy A; Aveyard, Paul; Beltcheva, Olga; Brown, Sandra A; Cannon, Dale S; Cichon, Sven; Corley, Robin P; Dahmen, Norbert; Degenhardt, Louisa; Foroud, Tatiana; Gaebel, Wolfgang; Giegling, Ina; Glatt, Stephen J; Grucza, Richard A; Hardin, Jill; Hartmann, Annette M; Heath, Andrew C; Herms, Stefan; Hodgkinson, Colin A; Hoffmann, Per; Hops, Hyman; Huizinga, David; Ising, Marcus; Johnson, Eric O; Johnstone, Elaine; Kaneva, Radka P; Kendler, Kenneth S; Kiefer, Falk; Kranzler, Henry R; Krauter, Ken S; Levran, Orna; Lucae, Susanne; Lynskey, Michael T; Maier, Wolfgang; Mann, Karl; Martin, Nicholas G; Mattheisen, Manuel; Montgomery, Grant W; Müller-Myhsok, Bertram; Murphy, Michael F; Neale, Michael C; Nikolov, Momchil A; Nishita, Denise; Nöthen, Markus M; Nurnberger, John; Partonen, Timo; Pergadia, Michele L; Reynolds, Maureen; Ridinger, Monika; Rose, Richard J; Rouvinen-Lagerström, Noora; Scherbaum, Norbert; Schmäl, Christine; Soyka, Michael; Stallings, Michael C; Steffens, Michael; Treutlein, Jens; Tsuang, Ming; Wall, Tamara L; Wodarz, Norbert; Yuferov, Vadim; Zill, Peter; Bergen, Andrew W; Chen, Jingchun; Cinciripini, Paul M; Edenberg, Howard J; Ehringer, Marissa A; Ferrell, Robert E; Gelernter, Joel; Goldman, David; Hewitt, John K; Hopfer, Christian J; Iacono, William G; Kaprio, Jaakko; Kreek, Mary Jeanne; Kremensky, Ivo M; Madden, Pamela A F; McGue, Matt; Munafò, Marcus R; Philibert, Robert A; Rietschel, Marcella; Roy, Alec; Rujescu, Dan; Saarikoski, Sirkku T; Swan, Gary E; Todorov, Alexandre A; Vanyukov, Michael M; Weiss, Robert B; Bierut, Laura J; Saccone, Nancy L
- Year
- 2016
- Journal
- Behavior genetics
- PMID
- 26392368
- DOI
- 10.1007/s10519-015-9737-3
- PMCID
- PMC4752855
The mu1 opioid receptor gene, OPRM1, has long been a high-priority candidate for human genetic studies of addiction. Because of its potential functional significance, the non-synonymous variant rs1799971 (A118G, Asn40Asp) in OPRM1 has been extensively studied, yet its role in addiction has remained unclear, with conflicting association findings. To resolve the question of what effect, if any, rs1799971 has on substance dependence risk, we conducted collaborative meta-analyses of 25 datasets with over 28,000 European-ancestry subjects. We investigated non-specific risk for "general" substance dependence, comparing cases dependent on any substance to controls who were non-dependent on all assessed substances. We also examined five specific substance dependence diagnoses: DSM-IV alcohol, opioid, cannabis, and cocaine dependence, and nicotine dependence defined by the proxy of heavy/light smoking (cigarettes-per-day >20 vs. ≤ 10). The G allele showed a modest protective effect on general substance dependence (OR = 0.90, 95% C.I. [0.83-0.97], p value = 0.0095, N = 16,908). We observed similar effects for each individual substance, although these were not statistically significant, likely because of reduced sample sizes. We conclude that rs1799971 contributes to mechanisms of addiction liability that are shared across different addictive substances. This project highlights the benefits of examining addictive behaviors collectively and the power of collaborative data sharing and meta-analyses.
Forest plot of general substance dependence and rs1799971 across studies that had at least 5 cases and 5 controls. Summary odds ratio, 95% Confidence Interval, and p-values are based on fixed effect meta-analysis. *indicates the subset of 10 studies that had all five specific substance dependence diagnoses, examined in secondary analyses to confirm consistency of results. Estimated heterogeneity variance was Q = 20.13 with a p-value of 0.387 among all 20 studies and Q = 6.49 with a p-value of 0.69 among the subset of 10 studies.
Forest plot of general substance dependence and rs1799971 across studies that had at least 5 cases and 5 controls. Summary odds ratio, 95% Confidence Interval, and p-values are based on fixed effect meta-analysis. *indicates the subset of 10 studies that had all five specific substance dependence diagnoses, examined in secondary analyses to confirm consistency of results. Estimated heterogeneity variance was Q = 20.13 with a p-value of 0.387 among all 20 studies and Q = 6.49 with a p-value of 0.69 among the subset of 10 studies.
1–20 of 40
Next →
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Pharmacogenetic association study of cannabis use in chronic pain. | Beauchesne W et al. | — | 2026 | → |
| Transcription factors implicated in substance use disorder, from immediate early genes to altered gene expression. | Orr E et al. | — | 2026 | → |
| Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study. | Juya F et al. | — | 2025 | → |
| Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study. | Juya F et al. | — | 2025 | → |
| Molecular and Environmental Determinants of Addictive Substances. | Lorek M et al. | — | 2024 | → |
| Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment. | Dunn KE et al. | — | 2024 | → |
| Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy. | Zeine F et al. | — | 2024 | → |
| Stigmata that are desired: Contradictions in addiction. | Vanyukov MM | — | 2024 | → |
| Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population. | Bagher AM et al. | — | 2023 | → |
| Association between opioid and dopamine receptor gene polymorphisms OPRM1 rs1799971, DAT VNTR 9-10 repeat allele, DRD1 rs4532 and DRD2 rs1799732 and alcohol dependence: an ethnicity oriented meta-analysis. | Suresh N et al. | — | 2023 | → |
| Distribution of pharmacogene allele and phenotype frequencies in Brazilian psychiatric patients. | May GB et al. | — | 2023 | → |
| Multi-ancestry study of the genetics of problematic alcohol use in >1 million individuals | Zhou H et al. | — | 2023 | — |
| Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. | Zhou H et al. | — | 2023 | → |
| [Polymorphisms of OPRM1, OPRK1, DCC genes and non-suicidal self-injuries in adults]. | Kibitov AA et al. | — | 2023 | → |
| The collaborative study on the genetics of alcoholism: Genetics. | Johnson EC et al. | — | 2023 | → |
| A Gateway That Never Was. | Vanyukov MM | — | 2022 | → |
| Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. | Gaddis N et al. | — | 2022 | → |
| Mu opioid receptor gene variant modulates subjective response to smoked cannabis. | Bourgault Z et al. | — | 2022 | → |
| Positive associations between cannabis and alcohol use polygenic risk scores and phenotypic opioid misuse among African-Americans. | Rabinowitz JA et al. | — | 2022 | → |
| Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review. | White O et al. | — | 2022 | → |
| Adolescent cannabis and tobacco use are associated with opioid use in young adulthood-12-year longitudinal study in an urban cohort. | Thrul J et al. | — | 2021 | → |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | — | 2021 | → |
| Different biases in meta-analyses of case-control and cohort studies: an example from genomics and precision medicine. | Palumbo SA et al. | — | 2021 | → |
| Genetic Vulnerability to Opioid Addiction. | Reed B et al. | — | 2021 | → |
| Identification of a sex-stratified genetic algorithm for opioid addiction risk. | Bright D et al. | — | 2021 | → |
| Molecular genetics of substance use disorders: An umbrella review. | Lopez-Leon S et al. | — | 2021 | → |
| Review and Consensus on Pharmacogenomic Testing in Psychiatry. | Bousman CA et al. | — | 2021 | → |
| The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients. | Thomas PS et al. | — | 2021 | → |
| Alcohol Cue-Induced Ventral Striatum Activity Predicts Subsequent Alcohol Self-Administration. | Lim AC et al. | — | 2020 | → |
| Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study. | Zhou H et al. | — | 2020 | → |
| Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference. | Collins D et al. | — | 2020 | → |
| Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of <i>OPRM1</i> A/G Polymorphism on Its Effectiveness. | Verholleman A et al. | — | 2020 | → |
| Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial: A Post Hoc Exploration. | Grunebaum MF et al. | — | 2020 | → |
| Pharmacotherapies and personalized medicine for alcohol use disorder: a review. | Lohoff FW | — | 2020 | → |
| Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder. | Hartwell EE et al. | — | 2020 | → |
| The μ-opioid receptor gene A118G polymorphism is associated with insecure attachment in children with disruptive mood regulation disorder and their mothers. | Cimino S et al. | — | 2020 | → |
| A review of opioid addiction genetics. | Crist RC et al. | — | 2019 | → |
| Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone. | Jones JD et al. | — | 2019 | → |
| Association Study of OPRM1 Gene in a Sample of Schizophrenia Patients With Alcohol Dependence or Abuse. | Gendy MNS et al. | — | 2019 | → |
| Binge-Like Eating Is Not Influenced by the Murine Model of <i>OPRM1</i> A118G Polymorphism. | Sachdeo BLY et al. | — | 2019 | → |
| Characterization of DSM-IV Opioid Dependence Among Individuals of European Ancestry. | Brick LA et al. | — | 2019 | → |
| Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia. | Kaski SW et al. | — | 2019 | → |
| Genomewide Gene-by-Sex Interaction Scans Identify ADGRV1 for Sex Differences in Opioid Dependent African Americans. | Yang BZ et al. | — | 2019 | → |
| <i>OPRM1</i> A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. | Taqi MM et al. | — | 2019 | → |
| Multivariate Analyses Reveal Biological Components Related to Neuronal Signaling and Immunity Mediating Electroencephalograms Abnormalities in Alcohol-Dependent Individuals from the Collaborative Study on the Genetics of Alcoholism Cohort. | Meda SA et al. | — | 2019 | → |
| The Colorado Twin Registry: 2019 Update. | Corley RP et al. | — | 2019 | → |
| The concept of exposure when selecting comparison groups for determining individual susceptibility to addiction to cigarette smoking. | Henn IW et al. | — | 2019 | → |
| Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence. | Loftis JM et al. | — | 2019 | → |
| A Critical Review of Methods and Results in the Search for Genetic Contributors to Alcohol Sensitivity. | Schuckit MA | — | 2018 | → |
| A prospective, longitudinal study to evaluate the clinical utility of a predictive algorithm that detects risk of opioid use disorder. | Brenton A et al. | — | 2018 | → |
| Endogenous Opiates and Behavior: 2016. | Bodnar RJ | — | 2018 | → |
| Heroin-induced suppression of saccharin intake in OPRM1 A118G mice. | Freet CS et al. | — | 2018 | → |
| Human Genetics of Addiction: New Insights and Future Directions. | Hancock DB et al. | — | 2018 | → |
| Informing Prevention and Intervention Policy Using Genetic Studies of Resistance. | Maher BS et al. | — | 2018 | → |
| Molecular Genetics and New Medication Strategies for Opioid Addiction. | Hurd YL et al. | — | 2018 | → |
| Oprm1 A112G, a single nucleotide polymorphism, alters expression of stress-responsive genes in multiple brain regions in male and female mice. | Collins D et al. | — | 2018 | → |
| Parental overcontrol x OPRM1 genotype interaction predicts school-aged children's sympathetic nervous system activation in response to performance challenge. | Partington LC et al. | — | 2018 | → |
| Pharmacogenetics of Methadone Response. | Fonseca F et al. | — | 2018 | → |
| Role of placebo effects in pain and neuropsychiatric disorders. | Belcher AM et al. | — | 2018 | → |
| Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease. | Cormier-Dequaire F et al. | — | 2018 | → |
| The frequency of <i>DRD2</i> rs1076560 and <i>OPRM1</i> rs1799971 in substance use disorder patients from the United Arab Emirates. | Alblooshi H et al. | — | 2018 | → |
| The genetic and environmental architecture of substance use development from early adolescence into young adulthood: a longitudinal twin study of comorbidity of alcohol, tobacco and illicit drug use. | Waaktaar T et al. | — | 2018 | → |
| The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption. | Sloan ME et al. | — | 2018 | → |
| A brief review of the genetics and pharmacogenetics of opioid use disorders. | Berrettini W | — | 2017 | → |
| A cis-eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use. | Otto JM et al. | — | 2017 | → |
| Alcohol Misuse Across the Lifespan: Insights from Developmental Studies in Behavior Genetics. | Savage JE et al. | — | 2017 | → |
| Collaborative Counseling Considerations for Pharmacogenomic Tests. | Zierhut HA et al. | — | 2017 | → |
| Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems. | Yeung EW et al. | — | 2017 | → |
| Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1. | Smith AH et al. | — | 2017 | → |
| Interaction Between the μ-Opioid Receptor Gene and the Number of Heavy-Drinking Peers on Alcohol Use. | Zaso MJ et al. | — | 2017 | → |
| Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder. | Brenton A et al. | — | 2017 | → |
| Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. | Cservenka A et al. | — | 2017 | → |
| The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment. | Levran O et al. | — | 2017 | → |
| Validation Study of a Predictive Algorithm to Evaluate Opioid Use Disorder in a Primary Care Setting. | Sharma M et al. | — | 2017 | → |
| Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability. | Karjalainen T et al. | — | 2016 | → |
| Gene Expression Changes in Glutamate and GABA-A Receptors, Neuropeptides, Ion Channels, and Cholesterol Synthesis in the Periaqueductal Gray Following Binge-Like Alcohol Drinking by Adolescent Alcohol-Preferring (P) Rats. | McClintick JN et al. | — | 2016 | → |
| Genetic background and epigenetic modifications in the core of the nucleus accumbens predict addiction-like behavior in a rat model. | Flagel SB et al. | — | 2016 | → |
| Genome-Wide Association of Heroin Dependence in Han Chinese. | Kalsi G et al. | — | 2016 | → |
| Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype. | Ziauddeen H et al. | — | 2016 | → |
| Risk and resistance perspectives in translation-oriented etiology research. | Vanyukov MM et al. | — | 2016 | → |